Zobrazeno 1 - 10
of 113
pro vyhledávání: '"L Laufman"'
Autor:
J. S. Gallagher, R. Kotulla, L. Laufman, E. Geist, S. Aalto, N. Falstad, S. König, J. Krause, G. C. Privon, C. Wethers, A. Evans, M. Gorski
Publikováno v:
The Astrophysical Journal Supplement Series, Vol 274, Iss 1, p 3 (2024)
Zw 049.057 is a moderate-mass, dusty, early-type galaxy that hosts a powerful compact obscured nucleus (CON, L _FIR,CON ≥ 10 ^11 L _⊙ ). The resolution of the Hubble Space Telescope enabled measurements of the stellar light distribution and chara
Externí odkaz:
https://doaj.org/article/9c11e293e6964e8685cd25f6fcaa59d3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Nykyforchyn, Edward A. Graviss, Fehmida Visnegarwala, M. Caprio, M. C. Rodriguez-Barradass, L. Laufman
Publikováno v:
AIDS Care. 18:332-338
Sustained virological suppression requires adherence to95% of doses of therapy. Overall there is paucity of data on adherence interventions among women and post-intervention outcomes. In this pilot study, we evaluated a novel strategy of weekly deliv
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Beth Overmoyer, Peter M. Ravdin, Walter J. Urba, S. Sundaram, Stephen E. Jones, L. Laufman, L. Hutchins, D. Richards, S. Olsen, Elyse E. Lower, R. Mennel, John K. Erban, Kathleen I. Pritchard, G.T. Budd, M.L. Meyers
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(24)
Purpose This randomized, controlled, multicenter, open-label, phase III study compared docetaxel versus paclitaxel in patients with advanced breast cancer that had progressed after an anthracycline-containing chemotherapy regimen. Patients and Method
Publikováno v:
All Days.
Due to major commercial production potential on Sakhalin Island in the Russian Federation, oil and gas industry scenarios project a significant workforce of 10,000 – 30,000, plus dependants and subcontractors. Such a large workforce will require ma
Autor:
Martin Schuler, L. Laufman, D. J. Stewart, F. A. Shepherd, Christoph Huber, J. A. Horowitz, U. Gatzemeier, A. K. Stewart, C. Rochlitz, Roland Buhl, Friedrich Kommoss, Jürgen Kuball, R. Gralla, Mary Ann Fritz, Claus P. Heussel, J. L.P. De Greve, R. Herrmann, A. P. Perruchoud
Publikováno v:
ResearcherID
PURPOSE: To study the additional benefit from adenoviral p53 gene therapy in patients undergoing first-line chemotherapy for advanced non–small-cell lung cancer (NSCLC). PATIENTS AND METHODS: Twenty-five patients with nonresectable NSCLC were enrol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c966265a8d4cedc78518a31d4d4543fa
https://biblio.vub.ac.be/vubir/adenovirusmediated-wildtype-p53-gene-transfer-in-patients-receiving-chemotherapy-for-advanced-nonsmallcell-lung-cancer-results-of-a-multicenter-phase-ii-study(ced29346-c646-4f35-aec9-95e7121a479e).html
https://biblio.vub.ac.be/vubir/adenovirusmediated-wildtype-p53-gene-transfer-in-patients-receiving-chemotherapy-for-advanced-nonsmallcell-lung-cancer-results-of-a-multicenter-phase-ii-study(ced29346-c646-4f35-aec9-95e7121a479e).html
Autor:
A. Weinberg, S. J. Sprankell, C. O. Frates, C. Browne, J. R. Bowling, B. U. Philips, G. Camp, E. Buck, B. C. Pence, J. B. Battles, M. Becker, J. Shores, J. B. Green, L. Baker, G. Smith, L. Laufman, S. Morell
Publikováno v:
Advances in Medical Education ISBN: 9789401060486
Screening and detection of cancer is often not adequately assessed. The Cancer Teaching and Curriculum Enhancement in Undergraduate Medicine (CATCHUM), a consortium of the eight medical schools in Texas, developed a set of multi-level OSCE stations t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::291f6d8f79544cb31fd8d526ca84d8e3
https://doi.org/10.1007/978-94-011-4886-3_123
https://doi.org/10.1007/978-94-011-4886-3_123
Autor:
M. A. Taylor, L. Laufman, J. Arnott, Kathy D. Miller, Bryan P. Schneider, Alison L. Hannah, M. Karwal, C. Sidor, L. Sylvester
Publikováno v:
Journal of Clinical Oncology. 26:1046-1046
1046 Background: MKC-1 is a novel oral cell cycle inhibitor with in vitro and in vivo activity against many tumor cell lines, including breast cancer. Proteins identified as binding targets of MKC-...